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Dengue virus (DENV) is one of the most important mosquito-borne viruses in tropical and subtropical
regions. Development of severe forms of dengue viral infection such as dengue fever (DF) and dengue
hemorrhagic fever (DHF) has claimed many lives. The standard methods for detecting dengue virus are
time consuming, laborious, and require skilful personnel. In this study, we propose a method whereby
DENV RNA extracted from dengue infected mosquitoes was converted into DNA for probe hybridization
to generate silver nanocluster strands that could be visualised under UV light. Label-free silver
nanocluster based DNA sensors are able to provide strong fluorescence upon DNA hybridization. Highly
specific DNA sequence detection is possible by taking advantage of the specificity of DNA hybridization
kinetics. The proposed system is capable of detecting all four dengue DNA serotypes (DENV1–4) without
any cross-reactivity. A single tube assay format showed better hybridisation efficiency with higher
fluorescence intensity generated and a lower detection limit compared to a cocktail probe assay format.
The method was able to detect as low as 100 nM of amplified double stranded dengue DNA targets
using both single and cocktail probe assays. This provides an interesting alternative approach for
multiplex DNA sensing utilizing DNA silver nanoclusters as a reporter system.1. Introduction
Dengue is regarded as a prevalent mosquito-borne viral disease
in tropical and subtropical countries.1Over the last few decades,
dengue virus infections have increased at an alarming rate with
390 million dengue outbreaks estimated per year.2 The intro-
duction of a new vaccine (Dengvaxia) against dengue infection
has helped to reduce the concern of dengue infections but the
vaccine has been reported to cause antibody dependent
enhancement (ADE) raising concerns of its use.3 The spread of
dengue beyond the traditional tropical and subtropical regions
has been reported mainly due to the higher rate of human
migration over the past decade.4 This infection is transmitted by
mosquitoes mainly Aedes aegypti which can cause symptoms
such as high fever, headache, stomach ache, rash, myalgia, and
arthralgia.5 Only a small percentage of infected individuals will
develop the severe form of dengue fever (DF) such as dengue
hemorrhagic fever (DHF), or dengue shock syndrome (DSS)
which are life-threatening.5,6 Early diagnosis in identifying the
disease is key for patient management and the regulation of
disease outbreak.7,8icine, Universiti Sains Malaysia, 11800
.my; Fax: +604-653-4803; Tel: +604-653-
, Universiti Malaysia Sarawak (UNIMAS),
niversiti Sains Malaysia, 11800 Minden,
tion (ESI) available. See DOI:There are four dengue serotypes: DENV-1, 2, 3, and 4.
Infection with any of the four dengue serotypes confers lifelong
immunity against the infected serotype. However, a subsequent
infection with a different serotype might lead to a more severe
infection due to ADE.9 Hence, DENV serotyping during the
transmission season could serve as an imperative measure in
epidemiological control of the disease.10 The gold standard
diagnosis for dengue infections involves the need to carry out
virus isolation, viral antigen or genomic RNA detection, or virus-
specic antibody detection.11,12 Despite higher sensitivity and
specicity, assays like virus isolation are laborious, time
consuming,13 require trained personnel and are unsuitable for
low titre virus samples.14 In addition to this, viral RNA can only
be detected 5 to 7 days aer infection which oen results in late
diagnosis.15 Antibody detection in serum is a common method
used to diagnose dengue infection due to its ease of handling.
However, detection of antibodies is not possible at the early
phase of infection due to low levels of IgM and IgG.16 The NS1
strip test has been introduced to diagnose dengue infection
rapidly via detection of dengue nonstructural protein 1 (NS1) by
coating NS1 specic antibodies on test membranes. However,
low sensitivity of NS1 detection has been reported in secondary
infection due to the formation of immune complexes between
NS1 antigen and existing antibodies.17
The advantage of RNA or cDNA detection systems for dengue
over antibody or antigen assays is the ability to amplify the
amount of RNA or cDNA available to detect samples at lower
levels. These detection systems are faster, with improved
sensitivity, and higher specicity.18–20 Several nucleic acid




































View Article Onlinedeveloped including loop-mediated isothermal amplication
(LAMP),21 DNA microarrays,21 real-time PCR (qPCR),22 reverse
transcriptase PCR (RT-PCR)23,24 and real-time reverse tran-
scriptase PCR.25 Each method has its own set of advantages and
disadvantages making alternative systems an intriguing
prospect.
LAMP is able to detect DNA rapidly with high specicity and
efficiency at a constant temperature. However, usually 4 to 6
primers are required to prime the specic regions for auto-
cycling strand displacement of DNA.26 The DNA microarray
assay is an interesting approach for high throughput screening
of low level cDNAs in sera. However, extensive skills and
knowledge are required for the fabrication and handling of DNA
microarrays.27 Therefore, this technique is scarcely used for the
detection of dengue virus. Real-time PCR (qPCR) and reverse
transcriptase (RT) PCR are the two most commonly applied
methods among nucleic acid sensing techniques due to their
high specicity and sensitivity.28 Real-time PCR especially is
reported to confer many advantages over conventional RT-PCR
by offering high throughput screening, lower sample handling
time, and the use of uorescence based reporters. The only
major setback of qPCR is the requirement of a specialised
instrument and trained personnel to perform the assays.29 RT-
PCR also provides a rapid and sensitive method for DENV
detection. However, detection of amplied DNA still requires
secondary methods like integration of ethidium bromide in
agarose gel,30 enzyme-linked immunosorbent assay,31 and
labelled oligonucleotide probes for hybridisation.30
In this work, silver nanoclusters (AgNCs) were used as the
readout indicator upon dengue gene amplication due to the
attractive features of AgNCs. Silver nanoclusters were rst re-
ported by Dickson and his group showing the formation of AgNCs
as a result of interactions between silver atoms and sequence
specic single-stranded DNA (ssDNA).32 Silver ions are able to
bind to the heterocyclic bases of DNA rather than the phosphate
or sugar groups. This interaction induces a conformational
change inDNAwhich decreases the DNAmobility in agarose gel.33
In addition to this, AgNCs are regarded as a noble metal nano-
cluster and a new class of uorophores which exhibit a wide
variety of attractive features.34 The synthesis of AgNCs is
straightforward and produces a brighter uorophore with good
photostability. Moreover, the spectroscopic properties of AgNCs
are tunable by adjusting the interaction between silver atoms and
the DNA sequence as well as the DNA length.35 In comparison to
other uorescent labels such as organic dyes and quantum dots,
AgNCs are an attractive alternative because AgNCs are brighter,
smaller in size, and non-toxic.36 Recent publications highlighting
the incorporation of AgNCs inDNA detection have been attracting
wide interest. DNA detection using AgNCs mostly relies on ana-
lysing AgNC spectra shis37 or “turn-on/turn-off” strategies.38,39
Here, we describe a DNA detection probe system for dengue
serotyping utilizing AgNC formation aer target assisted
isothermal exponential amplication (TAIEA). The target-
binding site of the probe was designed to complement the
target dengue cDNA. The focus on utilizing DNA instead of RNA
is due to the ease of sample handling, processing andmainly its
resistance to degradation when compared to RNA.40,41 TheThis journal is © The Royal Society of Chemistry 2018probes were designed to hybridise specically with the target
dengue DNA to initiate isothermal amplication before the
introduction of a nicking enzyme to promote the release of the
AgNC forming strands. Optimization of the proposed system
was performed using synthetic oligonucleotides, which was
later tested with amplied dengue DNA samples. As low as
100 nM of double stranded dengue DNA targets could be
detected using both single and cocktail probe assays with
uorescence spectrometry. The proposed system was able to
demonstrate specic detection of all four dengue serotypes.
2. Experimental
2.1 Reagents and materials
All oligonucleotides used were synthesized by Integrated DNA
Technologies (IDT) (Lowa, US). The sequences of all synthesized
oligonucleotides are shown in the ESI.† Vent (exo-) DNA poly-
merase and Nt.BstNBI nicking enzyme were purchased from
New England Biolabs (NEB) (Massachusetts, US). Sodium
borohydride (NaBH4) and silver nitrate (AgNO3) were purchased
from Fisher Scientic (Massachusetts, US).
2.2 Preparation of dengue RNA samples
DENV RNA was extracted from virus isolates obtained from
clinical dengue cases. Serum samples from clinically diagnosed
dengue patients were passaged through the C6/36 mosquito cell
line. Samples were serially passaged for up to 3 passages or until
the cytopathic effect (CPE) was observed. Then, the culture
supernatant was harvested for DENV RNA extraction when
greater than 80% CPE was observed. The concentrations of RNA
extracts were measured on a Nanodrop™ 2000/2000c spectro-
photometer (Thermo Fisher Scientic, Massachusetts, US).
Sample collection was carried out in compliance with the laws
and institutional guidelines approved by the Medical Research
and Ethics Committee, Ministry of Health Malaysia. Informed
consent for the use of the samples for the experiment was ob-
tained from the donors.
2.3 Preparation of dengue DNA samples
Reverse transcription of dengue RNA samples into cDNA was
done according to the manufacturer's protocol (SuperScript™
III Reverse transcriptase; Thermo Scientic Fisher, Massachu-
setts, US). A total of 2 mL of cDNA product was used in subse-
quent PCR amplication. The resulting PCR product was then
puried by ethanol precipitation and air-dried. The nal
product was resuspended in distilled water to a nal volume of
10 mL with distilled water. The concentration of the puried
PCR product was measured using a Nanodrop™ 2000/2000c
(Thermo Fisher Scientic, Massachusetts, US).
2.4 Isothermal amplication
The overall detection schematic for the target dengue sequence
with the serotype specic probes is illustrated in Fig. 1. Firstly,
0.3 mM of synthesised target dengue DNA was hybridised with
0.5 mM dengue probe in 2 mL of Buffer A (25 mM Tris–HNO3
(pH 7.9), 50 mM NaNO3, 5 mM Mg(NO3)2, and 0.5 mMAnal. Methods, 2018, 10, 214–222 | 215
Fig. 1 Overall schematic representation of a label-free DNA sensor for dengue DNA detection. (A) Dengue RNAwas first reverse transcribed into
single stranded cDNA before PCR amplification to double stranded DNA. (B) Target DNA was hybridised with a probe using a temperature
cascading program from 95 C to 25 C. (C) Target DNAwas extended by using DNA polymerase and nicked by using a nicking enzyme to release
the amplified targets and silver nanocluster strands. (D) Incubation of silver nanocluster strands with AgNO3 followed by reduction with NaBH4
generates silver nanoclusters. Fluorescence spectra of silver nanoclusters used in this assay are based on the excitation wavelength at 512 nm




































View Article Onlinedithiothreitol). The mixture was incubated with a temperature
cascading program from 95 C to 25 C (95 C, 80 C, 70 C,
50 C, 30 C, and 25 C) with each temperature point being
maintained for 5 minutes (min). Then, 3 mL of Buffer B (10 mM
NaNO3, 20 mM NH4NO3, 20 mM Tris–HNO3, pH 8.8, 2 mM
Mg(NO3)2, and 0.1% Triton X-100), 1.5 mM dNTPs, 0.17 U Vent
(exo-) DNA polymerase and 0.55 U of Nt.BstNBI nicking enzyme
were added to the mixture. Distilled water was added to the
mixture to a nal volume of 20 mL and incubated at 55 C for 5
hours (h) and stored at 4 C.2.5 Formation of silver nanoclusters
The resulting isothermal amplication mixture was mixed with
200 mM of AgNO3 and distilled water was added to a nal
reaction volume of 50 mL. The mixture was centrifuged at
12 000 rpm for 5 min. The supernatant was then collected and
incubated on ice in the dark for 15 min. Then, 60 mM of NaBH4
was freshly prepared and added to the mixture. The solution
was incubated in the dark at room temperature (rt) for 1 h.2.6 Visualization of the formation of silver nanoclusters
The formation of AgNCs upon reduction with NaBH4 was
determined using a uorescence spectrophotometer (Agilent
Varian Cary Ecplise, California, US). The excitation wavelength
was set at 512 nm and the emission was expected to be in the
range of 572 nm. The excitation slit was set at 10 nm and the
emission slit was set at 5 nm.3. Results and discussion
The design of the system for dengue DNA detection applies
a similar concept of isothermal amplication to that published216 | Anal. Methods, 2018, 10, 214–222previously42 with slight modications, where the probe was
designed with ve regions denoted as ‘ABABC’ as shown in
Fig. 1. Region A represents the region where the target dengue
DNA hybridizes as the template for isothermal amplication.
Hybridisation of the target to the probe was performed using
a cascading temperature program from 95 C to 25 C (Fig. 1B).
This would allow both the target oligonucleotides and probes to
be denatured at 95 C for the reduction of secondary structure
formation. Reducing the temperature from 95 C to 25 C at
a xed rate will allow both target and probes to come to prox-
imity for an improved percentage of successful hybridization.
Common practices for dengue diagnosis mainly surround
the use of either RNA or DNA samples for detection. However,
handling of the RNA sample is challenging due to the ease of
RNA degradation over a short period of time which requires
special and careful handling.43,44 Therefore, although viral RNA
is mainly obtained as the sample material, the conversion of
RNA to cDNA was carried out prior to detection. This also allows
the exibility for on-site sample collection with rapid cDNA
conversion for off-site analysis. This is a useful advantage when
managing outbreaks in resource limited settings.
Upon hybridization, the target will serve as the primer for
Vent (exo-) DNA polymerase to generate the complementary
strand of the dengue probe as shown in Fig. 1C. The nicking
enzyme (Nt.BstNBI) will then digest the oligonucleotide at the
specic site denoted as ‘B’ with a pre-dened sequence to
release the target and AgNC strand that is complementary to
sequence ‘C’. The released target strand will then hybridize with
another probe to repeat the similar process again. Successful
amplication and generation of AgNC strands upon dengue
target hybridisation was validated by agarose gel where the
formation of a band similar to the AgNC band (Fig. 2A) could be
observed. The formation of newly amplied AgNC strands isThis journal is © The Royal Society of Chemistry 2018
Fig. 2 Assay with synthetic target oligonucleotides. (A) Agarose gel analysis of silver nanocluster strand generation upon target hybridisation for
DNA amplification and nicking. (B) Specificity of single probes was tested for cross-reaction with all four dengue serotypes. Inset shows only




































View Article Onlineobserved from the agarose gel (Fig. 2A, Lane 3), which has a size
similar to the positive control AgNC strand (Fig. 2A, Lane 4).
Repeated cycles of amplication and nicking will eventually
generate substantial amounts of AgNC strands that will directly
inuence the level of uorescence under UV post-reduction with
sodium borohydride (NaBH4). Successful formation of AgNCs
exhibits uorescence emission at 572 nm upon excitation at
512 nm. In this study, detection of the probe is based on the
hybridisation of the target dengue DNA in region ‘A’. The DNA
was designed to target each dengue serotype specically based
on previously published sequences.10 Hence, four probes (P1,This journal is © The Royal Society of Chemistry 2018P2, P3, and P4) with sequence specic ‘A’ regions representing
all four serotypes were designed for dengue serotyping by the
generation of AgNC strands.
In this assay, incorporation of a label-free AgNC detection
method allows for an alternative sensing approach for DENV
serotyping. The ease of synthesis and non-toxic nature of AgNCs
coupled with the improved photostability and brighter uo-
rescence readout compared to gold nanoclusters make AgNCs
ideal for DNA sensing.36 Moreover the uorescence emission of
AgNC is tunable by DNA sequence programming.36,45–47 The




































View Article Onlineof them having been used in miRNA detection,42,46 cell
imaging,48 sensing,49,50 cell labelling,51 nucleic acid detection52,53
and drug delivery.54 The uorescence intensity generated by
AgNCs could be measured by using a uorescence spectro-
photometer since there is a direct correlation between the
uorescence intensity and AgNC concentration (Fig. S1†). The
uorescence intensity of AgNCs increases proportionally with
an increase in AgNC concentration with a cut-off point at
approximately 0.5 mM. This provides the basic working range of
the AgNC for detection to be between 0.5 mM and 3 mM of
AgNCs.
Optimization of the assay was carried out to obtain the best
working conditions for the system as shown in Table S3 and
Fig. S2.† Several factors were taken into consideration during
optimization, such as incubation temperature, concentration of
Vent (exo-) DNA polymerase, Nt.BstNBI nicking enzyme
concentration, incubation time for amplication and nicking
process, concentration of NaBH4 and concentration of silver
nitrate (AgNO3).
The optimum working temperature for Vent (exo-) DNA
polymerase and Nt.BstNBI nicking enzyme was determined to
be 75 C and 55 C respectively. This is because Nt.BstNBI has
a lower thermal stability compared to Vent (exo-) DNA poly-
merase. The Nt.BstNBI nicking activity is terminated at 80 C
due to protein denaturation. Hence, the optimum incubation
temperature for this assay was determined to be within the
range of 50 C to 65 C. The incubation time was optimized to
ensure that a maximum amount of product was generated from
the template. Fig. S2B† demonstrates the effects of short incu-
bation time on the amplication yield. The amount of DNA was
seen to increase over time until a maximum yield at 5 h,
whereas the amount started to decrease at 6 h. This decrease
could be associated with the amount of dNTPs present that
could be spent resulting in lower amounts of DNA being
generated. This is expected, as a longer incubation time will
ensure continuous amplication until all dNTPs are spent. The
concentration of Vent (exo-) DNA polymerase and Nt.BstNBI was
also optimized to ensure efficient use of the enzymes for
improved amplication conditions. An insufficient amount of
enzyme can result in lower yields while excess amounts of
enzyme will result in an increased cost. It was likely that higher
concentrations of the enzymes could also facilitate higher
polymerization and nicking rates resulting in higher amounts
of AgNC strands being formed. This could eventually lead to the
formation of more AgNCs, which will yield higher uorescence
intensities. However, we found that an increase in enzyme
concentrations beyond the optimum point did not inuence the
uorescence intensity as it has reached a maximum output.
Fig. S2C and D† depict an increase in uorescence intensities
with an increase in enzyme concentration. The formation of
AgNCs involves two vital components: NaBH4 and AgNO3. The
ratio of these two components has always been xed at 1 : 6 : 6,
1 : 12 : 12, or 1 : 18 : 18.50,55–57 An equal molar ratio of AgNO3
and NaBH4 is always applied in the formation of AgNCs because
one mole of NaBH4 is needed to reduce one mole of AgNO3 into




this paper however, the molar ratio of AgNO3 was three times218 | Anal. Methods, 2018, 10, 214–222higher than that of NaBH4. Lower ratios were found to result in
lower signals that were insufficient for detection. This is likely
due to the tendency of silver ions from AgNO3 to bind proteins
(DNA polymerase and nicking enzyme), similarly to the silver-
staining concept of proteins in polyacrylamide gels. When the
incubated product was centrifuged aer AgNO3 addition, the
silver ions were seen to bind to proteins and could be pelleted
down at the bottom of the tube as shown in Fig. S3.† Hence,
a higher molar ratio of AgNO3 to NaBH4 was applied to form
AgNCs. In addition to this, certain salts such as chloride ions
have also been reported to interfere with AgNC formation when
present at high concentrations.59 Chloride ions have been
shown to obstruct the formation of AgNCs via AgCl precipita-
tion or the sequestering of silver ions.59 Hence, chloride ions
were replaced with nitrate ions in the preparation of Buffer A
and Buffer B for the assay to avoid such issues.
The optimized conditions for amplication were determined
to be 55 C for 5 h with 0.17 U of Vent (exo-) DNA polymerase
and 0.55 U of Nt.BstNBI nicking enzyme. The optimized
conditions for the formation of AgNCs were determined to be
200 mM silver nitrate (AgNO3) with 60 mM NaBH4. Under the
optimized conditions, strong uorescence readouts were
generated within the correct emission wavelength.
The initial optimization for the detection system was per-
formed using just one serotype. However, to ensure that the
optimized conditions would apply to all the other serotypes,
detection of the different targets by their specic probes was
assessed individually. The cross-reactivity of the probes was
investigated by incubating oligonucleotides with different
dengue serotype sequences in competition. As shown in Fig. 2B
and Table S4a,† the designed probes were able to exhibit good
specicity with no cross-reactivity upon incubation with
competing sequences. The formation of AgNCs was not visible
when detection was carried out using non-matching serotype
sequence oligonucleotides to the serotype specic probes.
When the serotype specic targets were introduced to the
correct serotype probe pair, the formation of AgNCs was initi-
ated. This resulted in an increase in uorescence intensity for
that particular sample. Therefore it is possible to apply the
system for specic dengue detection and to an extent dengue
serotyping. The dependence on specic DNA sequence hybrid-
ization in the system ensures low background readings and
improved specicity.
The shelf life of AgNCs is greatly affected by their temporal
stability which is largely correlated with the binding affinity of
silver ions to DNA bases.60,61 Most AgNCs have short shelf lives
due to the oxidation rates.62 The shelf life of AgNCs is crucial for
the retention of uorescence intensity over a certain period of
time for detection especially when immediate documentation is
not possible. Also, applications of highly stable AgNCs as bio-
logical labels that have a long shelf life are highly sought
aer.63–65 The uorescence intensities of AgNCs generated from
all dengue serotypes were determined from 2 h to 7 days.
Fig. S3† demonstrates the increase in the uorescence intensity
of AgNCs aer incubation in the dark for one day. The uo-
rescence intensity remained relatively stable up to 72 hours




































View Article Onlineuorescence intensity is considered sufficiently high for detec-
tion even aer 7 days denoting the stability of AgNCs generated.
Upon conrming that each probe was able to generate
reporter strands with no cross-reactivity, the four probes were
mixed in an equal ratio to produce a cocktail consisting of
probes for all four serotypes. The single tube probe cocktail was
evaluated for its ability to detect the presence of each syn-
thesised serotype target sequence. Fig. 2C shows the successful
detection of all four dengue serotypes using the probe cocktail.
However, we did observe a slightly lower efficiency for detection
using the probe cocktail compared to the single probe detection
approach (Table S4b†). The drop in uorescence could be
attributed to the additional complexity associated with having
four different probes in a single assay. This could have inu-
enced the hybridisation efficiency to yield a lower uorescence
output but it did not interfere with the specicity of detection.
Both single probe and cocktail probe assays were later eval-
uated with detection of two dengue serotype targets concur-
rently. Reports of concurrent infections by more than one
dengue serotype are not new due to the increasing occurrence of
co-circulation of four dengue serotypes in the same area.19,66,67
Concurrent DENV infections have led to severe dengue clinical
manifestation.19,68 Fig. 3 demonstrates the detection of two
dengue serotypes using both single probe and cocktail probe
assays. DENV serotypes 2 and 3 were chosen here as a proof of
concept due to the higher virulence with an increased likeli-
hood to result in DHF outbreaks.69 Also, individuals infected
with DENV serotype 2 or 3 usually experience silent infec-
tions.70,71 We found that both systems were able to detect the
presence of the 2 serotypes at the same time. The cocktail probe
assay was able to detect two serotypes in one tube format with
a higher uorescence intensity compared to the detection of
a single serotype (Fig. 3A). However, the cocktail probe assay
was unable to differentiate the DENV serotype present in the
sample. The single probe assay on the other hand was able to
identify the DENV serotype that was present in the sample,
albeit with a lower uorescence intensity (Fig. 3B).
The dengue specic probes are designed to detect dengue
DNA specically based on the variable region from the RNA-
dependent RNA polymerase (RdRp) domain that is highlyFig. 3 Simultaneous detection of two dengue serotypes. (A) Single prob
This journal is © The Royal Society of Chemistry 2018conserved in avivirus genomes.72–74 Hence it would be crucial
for the probes to be able to differentiate between aviviruses.
Gene sequences from three different aviviruses (JEV: Japanese
Encephalitis Virus; YFV: Yellow Fever Virus; WNV: West Nile
Virus) were synthesised to investigate the cross-reactivity of the
dengue probes with other closely related aviviruses. As
demonstrated in Fig. S5,† the cocktail of dengue probes showed
high specicity towards dengue DNA with no cross-reactivity
with other tested aviviruses.
We evaluated the proposed system by applying samples ob-
tained from dengue virus cultures. Dengue RNA samples were
rst reverse transcribed to single stranded cDNA and later
amplied with dengue RNA specic primers. All four dengue
serotypes were successfully amplied as shown in Fig. 4A. These
samples were later used as targets of the proposed system to
generate AgNC strands. Amplied DNA showed that the single
probe assay was able to detect the dsDNA amplied from all
serotypes of the dengue RNA (Fig. 4B and Table S5†), while the
cocktail probe assay detection of amplied dengue DNA was not
consistent among serotypes. Dengue serotype 1 appeared to
hybridise better to the probes to give a higher uorescence
intensity compared to other serotypes. Dengue serotype 1 also
showed the highest uorescence intensity in the single probe
assay. This is expected as dengue target serotype 1 has the
lowest GC content and melting temperature (Tm) compared to
other primers as demonstrated in Table S6.† Hence, dengue
target serotype 1 in dsDNA form has the lowest DNA duplex
stability that requires the lowest temperature to dissociate into
the ssDNA form compared to other dengue serotypes. The
higher dissociation rate of duplex DNA into ssDNA enabled the
dengue target gene to hybridise faster to the probe.
The detection limit of the proposed system was evaluated
with DNA samples amplied from dengue virus RNA samples.
Target DNA concentrations ranging from 0 nM to 500 nM were
applied and the results are shown in Fig. 4C and D. The single
probe assay showed better detection limits when compared to
the cocktail probe assay. However, when the concentrations
were reduced, both single probe and cocktail probe assays were
unable to show clear differences in the generated uorescence
intensities. Overall, the uorescence intensities could bee assay. (B) Cocktail probe assay.
Anal. Methods, 2018, 10, 214–222 | 219
Fig. 4 Assay with dengue samples. (A) PCR amplification for all dengue serotypes. (B) Detection of amplified dengue DNA with both the single
probe assay and the cocktail probe assay. (C) Limit of detection for amplified dengue DNA with the single probe assay. (D) Limit of detection for




































View Article Onlinediscriminated between samples and controls at 100 nM of target
DNA using a uorescence spectrophotometer.
4. Conclusions
The proposed method was able to hybridise dengue virus
sequences for all serotypes successfully by isothermal ampli-
cation and nicking to generate sufficient reporter AgNC strands
for DNA sensing. The formation of AgNC strands could be
detected either by measuring the uorescence intensity using
a uorescence spectrophotometer or by visualisation using
a handheld UV lamp. Each serotype probe was able to detect its
specic target and did not exhibit any cross-reactivity with
probes of other serotypes. In order to have a single tube assay
format, a multi-probe cocktail was used to determine the
presence of dengue DNA sequences in the samples. The probe
cocktail platform was able to detect the target DNA with good
specicity but with a lower uorescence intensity compared to
single probe detection assays. Although the assay was able to
differentiate four closely related DNA sequences specically, we
do not ignore the challenge of the assay as a result of the need
for reverse transcription of dengue RNA before performing the
assay. However, existing isothermal reverse transcription
protocols can be adopted to overcome this shortcoming. In
summary, the proposed platform provides an interesting alter-
native for DNA sensing using AgNCs for dengue serotyping. In
addition to this, the ability of the assay to function as a single
probe assay and multi-probe cocktail assay also adds an extra
dimension to the assay as it can potentially function as
a multiplex DNA assay for the detection of other various
diseases.
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